Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Stock Short Interest Falls 33.9%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totaling 102,979 shares, a drop of 33.9% from the September 30th total of 155,699 shares. Based on an average daily volume of 263,817 shares, the short-interest ratio is presently 0.4 days.

Tevogen Bio Stock Down 2.0%

Shares of TVGNW stock opened at $0.08 on Wednesday. Tevogen Bio has a 12-month low of $0.03 and a 12-month high of $0.12. The stock’s 50-day moving average price is $0.06 and its 200-day moving average price is $0.05.

Tevogen Bio Company Profile

Tevogen Bio is a clinical-stage biotechnology company focused on developing precision T-cell therapies for patients with viral infections and other immune-related diseases. The company’s platform is designed to produce targeted, off-the-shelf therapies using virus-specific cytotoxic T lymphocytes, with the aim of providing treatment without the need to collect and modify each patient’s own cells.

Tevogen’s lead product candidate, TVGN 489, is an investigational allogeneic T-cell therapy intended to target SARS-CoV-2-infected cells.